NULOJIX
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0003-0371 -
Package NDC
0003-0371-13 -
Application number
BLA125288 -
SPL ID
9057087d-7e59-4e5a-8e4a-96a532efb0ab -
SPL set ID
c16ac648-d5d2-9f7d-8637-e2328572754e -
UNII
E3B2GI648A -
RxCUI
1112976 -
RxCUI
1112980
What the source publishes
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Active ingredients
- BELATACEPT
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NULOJIX",
"splId": "9057087d-7e59-4e5a-8e4a-96a532efb0ab",
"labels": [
{
"setId": "c16ac648-d5d2-9f7d-8637-e2328572754e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c16ac648-d5d2-9f7d-8637-e2328572754e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c16ac648-d5d2-9f7d-8637-e2328572754e"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "E.R. Squibb & Sons, L.L.C.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-0371-13) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE",
"package_ndc": "0003-0371-13",
"identifierStatus": "well-formed",
"marketing_start_date": "20110615"
}
],
"productId": "0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "0003-0371",
"deaSchedule": null,
"genericName": "BELATACEPT",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BELATACEPT",
"strength": "250 mg/1"
}
],
"applicationNumber": "BLA125288",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20110615",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000182829",
"N0000182830",
"N0000182150",
"N0000182151"
],
"unii": [
"E3B2GI648A"
],
"rxcui": [
"1112976",
"1112980"
],
"spl_set_id": [
"c16ac648-d5d2-9f7d-8637-e2328572754e"
],
"pharm_class_pe": [
"T Lymphocyte Costimulation Activity Blockade [PE]"
],
"pharm_class_epc": [
"Selective T Cell Costimulation Blocker [EPC]"
],
"pharm_class_moa": [
"CD80-directed Antibody Interactions [MoA]",
"CD86-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"E.R. Squibb & Sons, L.L.C."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0003-0371_9057087d-7e59-4e5a-8e4a-96a532efb0ab"